Table 1.

Clinical characteristics of study subjects

	Control	Inflammatory	Stricturing
Number (n)	39	17	18
Sex (% male)	44	59	67
Age range years (median)	2–17 (14)	6–17 (14)	8–18 (14)
Disease duration (months)	N/A	8.0 ± 2.9	11.3 ± 2.5
ESR (mm/hr)	10.0 ± 1.7	32.3 ± 6.7	35.7 ± 6.8
CRP (mg/dL)	0.5 ± 0.04	6.2 ± 3.7	9.3 ± 2.1
Hgb (g/dL)	13.6 ± 0.4	12.0 ± 0.4	11.4 ± 0.5
Previous treatments	Corticosteroid – 0 5-ASA – 0 Immunomodulator – 0 Biologic – 0 Antibiotic – 0	Corticosteroid – 6 5-ASA – 4 Immunomodulator – 6 Biologic – 1 Antibiotic – 5	Corticosteroid – 15 5-ASA – 4 Immunomodulator – 17 Biologic – 4 Antibiotic – 2
PCDAI	N/A	35.2 ± 1.9	37.6 ± 2.3

All values mean ± SEM.

No statistical difference between Inflammatory and Stricturing disease was obtained.